|1.||Ochiai, R Leon: 5 articles (05/2014 - 04/2007)|
|2.||Khan, M Imran: 4 articles (10/2014 - 05/2010)|
|3.||Mintz, Eric D: 4 articles (10/2014 - 01/2012)|
|4.||Clemens, John D: 4 articles (05/2014 - 04/2007)|
|5.||Sztein, Marcelo B: 4 articles (01/2014 - 03/2003)|
|6.||Kantele, Anu: 3 articles (01/2014 - 01/2012)|
|7.||Majumder, Partha P: 2 articles (06/2015 - 12/2009)|
|8.||Date, Kashmira A: 2 articles (06/2015 - 10/2014)|
|9.||Centers for Disease Control and Prevention (CDC): 2 articles (03/2015 - 10/2014)|
|10.||Martin, Laura B: 2 articles (01/2015 - 10/2012)|
|1.||Typhoid Fever (Typhoid)
01/01/2014 - "A major obstacle in the development of improved typhoid, as well as paratyphoid vaccines is the lack of known immunological correlates of protection in humans. "
02/01/1990 - "Typhoid vaccine efficacy for tourists was calculated and showed an overall protective rate of 90% against enteric fever in general, 95% protection against S typhi, and 72% to 75% protection against S paratyphi A. "
01/01/2014 - "25 years after Vi typhoid vaccine efficacy study, typhoid affects significant number of population in Nepal."
04/01/2012 - "We analysed the data from the control group in a typhoid vaccine trial in Karachi to assess the differences in individual-, household- and cluster-level characteristics for developing typhoid fever. "
12/01/2009 - "We conducted a study on 1,000 individuals resident in an area at high-risk for typhoid; vaccinated them with the typhoid vaccine, measured their antibody response to the vaccine, assayed >2,000 curated SNPs chosen from 283 genes that are known to participate in immune-response; and analyzed these data using a strategy to (a) minimize the statistical problems associated with testing of multiple hypotheses, and (b) internally cross-validate inferences, using a half-sample design, with little loss of statistical power. "
01/01/2015 - "Assessment of paratyphoid vaccine efficacy in preclinical studies is complicated by the lack of a small animal model and the human-restricted nature of the infection. "
01/01/2015 - "This study will develop the first human challenge model of paratyphoid infection which may then be taken forward to evaluate paratyphoid vaccine candidates. "
01/01/2014 - "Paratyphi A infections worldwide, the need to produce a paratyphoid vaccine is essential and urgent. "
07/01/2008 - "The infection however can be prevented by good sanitation, improving good water supply, the provision of proper sewage disposal system, as well as the effective use of the available typhoid vaccines. "
01/01/1967 - "typhi used until now gives a true infection and forms the basis of a reliable method for the potency assay of typhoid vaccines."
11/01/1955 - "Further studies have been made of a pyrogenic substance which appears in the circulation of rabbits during the course of experimental fever induced by injection of typhoid vaccine. "
05/01/2005 - "The present communication evaluated its antipyretic activity by using yeast-induced and TAB (Typhoid) vaccine-induced pyrexia in rats and rabbits. "
07/01/1984 - "In these cases, high fever (pyretotherapy) induced by TBA vaccine (typhoid and paratyphoid) was used. "
04/01/1965 - "FEVER PRODUCED BY MICROINJECTION OF TYPHOID VACCINE INTO HYPOTHALAMUS OF CATS."
11/01/1962 - "[THE EFFECT OF HUANG CH'IN ON TYPHOID VACCINE INDUCED FEVER IN RABBITS]."
|4.||Salmonella Infections (Salmonellosis)
09/01/2010 - "Because of the potential importance of HLA-E-restricted CD8(+) responses in resistance to Salmonella infection, we characterized these responses and investigated their kinetics of appearance and persistence in volunteers immunized orally with the licensed attenuated Ty21a strain typhoid vaccine. "
10/27/1956 - "Typhoid-paratyphoid vaccine with chloramphenicol in recurrences of salmonellosis."
06/19/2015 - "Although the prudent use of effective antimicrobials, improved hygiene and sanitation and the discovery of new antimicrobial agents may offer hope for the management of invasive salmonella infections, it is essential to consider other interventions including the wider use of WHO recommended typhoid vaccines and the acceleration of trials for novel iNTS vaccines. "
04/01/1958 - "[Role of paratyphoid vaccine in control of tertiary malaria]."
09/01/2001 - "From computerized pharmacy records, we identified 101 children 18 years of age or younger from six different facilities of Kaiser Permanente in northern California who obtained malaria prophylaxis, typhoid vaccine, or yellow fever vaccine for international travel from their primary care practitioner. "
11/01/1987 - "Besides strategies to minimize the risks of malaria and hepatitis, recommendations for improving missionary health include greater use of rabies and typhoid vaccines; increased attention to mental health concerns and accident prevention, particularly seat belt use; increased health education regarding both clinical issues and public health principles; improved scheduling for relaxation and family time; and greater availability of comprehensive health services before departing, while abroad, and upon returning from an overseas assignment."
09/01/2008 - "The median amount that participants were prepared to pay for a full travel assessment was pound 10, pound 13 for the administration of typhoid vaccine, pound 70 for a course of rabies vaccine, and pound 25 for malaria tablets for Kenya. "
|1.||Phenol (Carbolic Acid)
|4.||Anti-Infective Agents (Microbicides)
|5.||Tetanus Toxoid (Vaccine, Tetanus)
|8.||Diphtheria-Tetanus-Pertussis Vaccine (DPT Vaccine)
|10.||Typhoid-Paratyphoid Vaccines (Typhoid Vaccines)
|2.||Seat Belts (Seat Belt)